TXN and Cognitive impairment: To analyze Trx80 levels during AD progression, we quantified Trx80 in CSF from controls, from patients with stable mild cognitive impairment without progression to AD (MCI), MCI-progressive to AD (MCI-AD), or mild AD by a highly sensitive sandwich enzyme-linked immunosorbent assay (ELISA).